HCA Healthcare, Inc. (BMV:HCA)
Mexico · Delayed Price · Currency is MXN 7,792.88
0.00 (0.00%)
At close: Oct 9, 2025
HCA Healthcare Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 6,884 | 6,657 | 6,091 | 6,834 | 7,721 | 4,387 | Upgrade |
Depreciation & Amortization | 3,421 | 3,312 | 3,077 | 2,969 | 2,853 | 2,721 | Upgrade |
Stock-Based Compensation | 358 | 360 | 262 | 341 | 440 | 362 | Upgrade |
Other Adjustments | 1,148 | 291 | 458 | -470 | -1,552 | 484 | Upgrade |
Change in Receivables | -194 | -799 | -935 | -797 | -962 | 327 | Upgrade |
Changes in Inventories | -25 | 334 | -126 | -59 | -540 | -304 | Upgrade |
Changes in Accounts Payable | 142 | 359 | 604 | -296 | 999 | 1,255 | Upgrade |
Operating Cash Flow | 11,935 | 10,514 | 9,431 | 8,522 | 8,959 | 9,232 | Upgrade |
Operating Cash Flow Growth | 24.41% | 11.48% | 10.67% | -4.88% | -2.96% | 21.44% | Upgrade |
Capital Expenditures | -4,643 | -4,875 | -4,744 | -4,395 | -3,577 | -2,835 | Upgrade |
Payments for Business Acquisitions | -461 | -266 | -635 | -224 | -1,105 | -568 | Upgrade |
Proceeds from Business Divestments | 184 | 328 | 193 | 1,237 | 2,160 | 68 | Upgrade |
Other Investing Activities | -61 | -120 | -131 | -7 | -121 | -58 | Upgrade |
Investing Cash Flow | -4,981 | -4,933 | -5,317 | -3,389 | -2,643 | -3,393 | Upgrade |
Short-Term Debt Issued | - | -1,880 | -1,020 | 120 | 2,780 | -2,480 | Upgrade |
Net Short-Term Debt Issued (Repaid) | - | -1,880 | -1,020 | 120 | 2,780 | -2,480 | Upgrade |
Long-Term Debt Issued | - | 7,495 | 3,224 | 5,997 | 4,344 | 2,700 | Upgrade |
Long-Term Debt Repaid | -5,801 | -2,410 | -909 | -2,830 | -3,869 | -3,437 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -5,801 | 5,085 | 2,315 | 3,167 | 475 | -737 | Upgrade |
Repurchase of Common Stock | -8,506 | -6,042 | -3,811 | -7,000 | -8,215 | -441 | Upgrade |
Net Common Stock Issued (Repurchased) | -8,506 | -6,042 | -3,811 | -7,000 | -8,215 | -441 | Upgrade |
Common Dividends Paid | -685 | -690 | -661 | -653 | -624 | -153 | Upgrade |
Other Financing Activities | -944 | -1,055 | -917 | -1,290 | -1,071 | -866 | Upgrade |
Financing Cash Flow | -6,857 | -4,582 | -4,094 | -5,656 | -6,655 | -4,677 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 11 | -1 | 7 | -20 | -3 | 10 | Upgrade |
Net Cash Flow | 108 | 998 | 27 | -543 | -342 | 1,172 | Upgrade |
Beginning Cash & Cash Equivalents | 831 | 935 | 908 | 1,451 | 1,793 | 621 | Upgrade |
Ending Cash & Cash Equivalents | 939 | 1,933 | 935 | 908 | 1,451 | 1,793 | Upgrade |
Free Cash Flow | 7,292 | 5,639 | 4,687 | 4,127 | 5,382 | 6,397 | Upgrade |
Free Cash Flow Growth | 29.31% | 20.31% | 13.57% | -23.32% | -15.87% | 85.74% | Upgrade |
FCF Margin | 10.03% | 7.99% | 7.21% | 6.85% | 9.16% | 12.41% | Upgrade |
Free Cash Flow Per Share | 28.98 | 21.54 | 16.96 | 14.01 | 16.37 | 18.62 | Upgrade |
Levered Free Cash Flow | -935 | 8,095 | 5,348 | 7,149 | 9,946 | 1,374 | Upgrade |
Unlevered Free Cash Flow | 7,580 | 7,368 | 6,420 | 5,430 | 7,334 | 6,704 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.